Literature DB >> 29402675

The provision of cell phones as a recruitment and retention strategy for people who inject drugs enrolling in a randomized trial.

Catherine Stewart1, Hannah Kopinski2, Jane Liebschutz2, Inga Holmdahl2, Julia Keosaian1, Debra Herman3, Bradley Anderson3, Michael Stein4.   

Abstract

BACKGROUND: Studies of drug-using populations often restrict enrollment by limiting participation to those with a working telephone. It is unknown whether supplying phones could broaden recruitment and sustain retention among an urban population of people who inject drugs (PWID). We compare the feasibility of offering pay-by-month phones to gift card compensation as part of an ongoing randomized controlled trial of hospitalized PWID.
METHODS: Participants were recruited from inpatient services at an urban hospital in Boston, MA to participate in an ongoing randomized trial testing a motivational interviewing (MI) intervention. Participants who did not have their own phone at the time of enrollment were offered a pay-by-month phones as compensation for study participation.
RESULTS: Eighty-one participants met study criteria, were enrolled, and completed the study at the time of analysis. We used a generalized estimating equation to compare the overall likelihood of attending interviews during the 12-month follow-up period. Participants receiving phones tended to have lower mean educational attainment (11.4 years vs. 12.1 years), were significantly (Fisher's exact p < 0.001) more likely to report homelessness during the past 90 days (86.7% vs. 37.3%), and were significantly less likely (Fisher's exact p = .044) to be employed (3.3% vs. 20.4%) compared to those receiving gift cards. Participants in each group were equally likely to attend follow-up interviews during the study (83.3% vs. 88.3%, p = 0.53).
CONCLUSION: Offering phones as a compensation method allows recruitment of a more disenfranchised population without impacting study retention and therefore may improve generalizability of study results.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Injection drug use; Longitudinal; Recruitment; Retention; Tracking

Mesh:

Year:  2018        PMID: 29402675      PMCID: PMC5818325          DOI: 10.1016/j.drugalcdep.2017.11.019

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  24 in total

1.  Correlates of treatment follow-up difficulty.

Authors:  Susanna Nemes; Eric Wish; Brook Wraight; Nena Messina
Journal:  Subst Use Misuse       Date:  2002-01       Impact factor: 2.164

2.  Posttraumatic Stress Disorder and Co-Occurring Substance Use Disorders: Advances in Assessment and Treatment.

Authors:  Jenna L McCauley; Therese Killeen; Daniel F Gros; Kathleen T Brady; Sudie E Back
Journal:  Clin Psychol (New York)       Date:  2012-09-01

3.  Maximizing retention in community-based clinical trials.

Authors:  Linda Lindsey Davis; Marion E Broome; Ruth P Cox
Journal:  J Nurs Scholarsh       Date:  2002       Impact factor: 3.176

Review 4.  Tracking and follow-up of marginalized populations: a review.

Authors:  M McKenzie; J P Tulsky; H L Long; M Chesney; A Moss
Journal:  J Health Care Poor Underserved       Date:  1999-11

5.  Recruiting and retaining mobile young injection drug users in a longitudinal study.

Authors:  Stephen E Lankenau; Bill Sanders; Dodi Hathazi; Jennifer Jackson Bloom
Journal:  Subst Use Misuse       Date:  2010-04       Impact factor: 2.164

6.  Relationship between follow-up rates and treatment outcomes in substance abuse research: more is better but when is "enough" enough?

Authors:  M L Hansten; L Downey; D B Rosengren; D M Donovan
Journal:  Addiction       Date:  2000-09       Impact factor: 6.526

7.  Attrition in longitudinal studies: who do you lose?

Authors:  Anne F Young; Jennifer R Powers; Sandra L Bell
Journal:  Aust N Z J Public Health       Date:  2006-08       Impact factor: 2.939

8.  The Use of Technology in Participant Tracking and Study Retention: Lessons Learned From a Clinical Trials Network Study.

Authors:  Shannon Gwin Mitchell; Robert P Schwartz; Anika A H Alvanzo; Monique S Weisman; Tiffany L Kyle; Eva M Turrigiano; Martha L Gibson; Livangelie Perez; Erin A McClure; Sara Clingerman; Autumn Froias; Danielle R Shandera; Robrina Walker; Dean L Babcock; Genie L Bailey; Gloria M Miele; Lynn E Kunkel; Michael Norton; Maxine L Stitzer
Journal:  Subst Abus       Date:  2015-02-11       Impact factor: 3.716

9.  Buprenorphine treatment for hospitalized, opioid-dependent patients: a randomized clinical trial.

Authors:  Jane M Liebschutz; Denise Crooks; Debra Herman; Bradley Anderson; Judith Tsui; Lidia Z Meshesha; Shernaz Dossabhoy; Michael Stein
Journal:  JAMA Intern Med       Date:  2014-08       Impact factor: 21.873

10.  Using facebook to maximize follow-up response rates in a longitudinal study of adults who use methamphetamine.

Authors:  Franklin Bolanos; Diane Herbeck; Dayna Christou; Katherine Lovinger; Aurora Pham; Adnan Raihan; Luz Rodriguez; Patricia Sheaff; Mary-Lynn Brecht
Journal:  Subst Abuse       Date:  2012-01-10
View more
  2 in total

1.  Perceived Behavioral Control and Barriers to Cleaning Skin Before Injecting Drugs.

Authors:  Shannon R Kenney; Kristina T Phillips; Debra S Herman; Julia Keosaian; Bradley J Anderson; Michael D Stein
Journal:  J Addict Med       Date:  2020 May/Jun       Impact factor: 4.647

2.  Feasibility and acceptability of mobile phone data collection for longitudinal follow-up among patients treated for obstetric fistula in Uganda.

Authors:  Alison M El Ayadi; Hadija Nalubwama; Justus K Barageine; Suellen Miller; Susan Obore; Othman Kakaire; Abner Korn; Felicia Lester; Nadia G Diamond-Smith; Haruna Mwanje; Josaphat Byamugisha
Journal:  Health Care Women Int       Date:  2020-10-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.